SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $6,018,560 | -7.5% | 128,000 | -17.4% | 0.94% | -13.5% |
Q1 2023 | $6,503,800 | +778.9% | 155,000 | +1712.0% | 1.09% | +1547.0% |
Q4 2020 | $740,000 | -94.0% | 8,554 | -93.3% | 0.07% | -95.2% |
Q4 2018 | $12,261,000 | +44.7% | 128,000 | +113.3% | 1.38% | +42.0% |
Q3 2018 | $8,475,000 | +58.8% | 60,000 | +85.2% | 0.97% | +55.4% |
Q4 2017 | $5,336,000 | +904.9% | 32,400 | +280.4% | 0.63% | +734.7% |
Q3 2017 | $531,000 | +33.4% | 8,518 | +70.4% | 0.08% | +10.3% |
Q2 2017 | $398,000 | -88.8% | 5,000 | -90.0% | 0.07% | -90.2% |
Q1 2017 | $3,554,000 | -22.7% | 50,000 | -44.4% | 0.70% | -40.2% |
Q4 2016 | $4,595,000 | -37.4% | 90,000 | -43.6% | 1.16% | -2.8% |
Q3 2016 | $7,345,000 | +250.8% | 159,500 | +129.5% | 1.20% | +119.9% |
Q2 2016 | $2,094,000 | -46.9% | 69,500 | -43.5% | 0.54% | -36.4% |
Q1 2016 | $3,943,000 | -27.3% | 123,000 | +32.3% | 0.86% | +7.7% |
Q4 2015 | $5,422,000 | +1499.4% | 93,000 | +1062.5% | 0.79% | +1746.5% |
Q3 2015 | $339,000 | -90.3% | 8,000 | -83.3% | 0.04% | -87.5% |
Q2 2015 | $3,504,000 | +6.1% | 48,000 | -27.0% | 0.34% | -0.3% |
Q1 2015 | $3,301,000 | +13.1% | 65,724 | -17.6% | 0.34% | -30.8% |
Q4 2014 | $2,918,000 | +5.3% | 79,724 | -9.3% | 0.50% | +45.3% |
Q3 2014 | $2,770,000 | – | 87,924 | – | 0.34% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |